GenoLogics Releases Clarity LIMS X as Part of Illumina SeqLab
News Jul 31, 2015
GenoLogics has announced the availability of Clarity LIMS X, an edition of its industry-leading laboratory informatics platform. Optimized for use with Illumina® SeqLab, the X Edition of Clarity LIMS provides positive sample tracking, maximizes quality and throughput, and improves turnaround time in population-scale genomics workflows.
The 2014 launch of the HiSeq X systems enabled labs to break the $1,000 barrier for human whole-genome sequencing. Labs are now addressing how to scale to throughput while maintaining a focus on quality and accuracy. The X Edition provides rapid scaling with automation and business logic built into preconfigured HiSeq X Series workflows.
Samples advance through the pipeline automatically, minimizing human interaction and the potential for error while enforcing quality standards. The X Edition of Clarity LIMS was designed based upon best practices from Genomics England Lab (GEL) and the Illumina FastTrack Services Lab, and is currently in use in both labs.
Clarity LIMS X Edition also provides e-signature, audit trails, and patient data security, making it suitable for regulated environments. According to Illumina Director of Scientific Research, Ryan Taft, Ph.D., “Clarity LIMS X closes the gap in providing a commercially available LIMS that includes out of the box instrument integration and positive sample tracking.”
“We are proud to partner with Illumina to provide the X Edition of Clarity LIMS for Illumina SeqLab,” says Michael Ball, CEO of GenoLogics. He adds, “This solution empowers scientists and clinicians to advance the understanding of disease and accelerate the integration of genomics into everyday healthcare.”
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Defects in Cell’s ‘Waste Disposal System’ Linked to Parkinson’sNews
An international study has shed new light on the genetic factors associated with Parkinson’s disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder.READ MORE
Mouse Model Demonstrates Potential of New Autism DrugNews
Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, largely corrected electrical, behavioral and brain abnormalities in the mice.READ MORE